Brinzolamide Intermediate (CAS 160982-16-1) | Advanced API Synthesis Component
Google Search Keywords: Brinzolamide Intermediate, CAS 160982-16-1, Carbonic Anhydrase Inhibitor Precursor, API Synthesis Material, Pharmaceutical Intermediates
🔬 Product Overview
Brinzolamide Intermediate (CAS 160982-16-1) is a high-purity chemical compound critical for the synthesis of Brinzolamide, a carbonic anhydrase inhibitor used to treat glaucoma and ocular hypertension. This intermediate ensures efficient, scalable production of Brinzolamide API while adhering to stringent pharmaceutical quality standards.
Primary Function: Enables precise and cost-effective manufacturing of Brinzolamide.
Applications: Pharmaceutical API production, generic drug development, process optimization.
✅ Key Advantages
⭐ Exceptional Purity
⚡ Streamlined Synthesis
🌡️ Storage Stability
📜 Regulatory Alignment
📋 Applications
API Manufacturing: Key precursor in Brinzolamide API batch production.
Generic Ophthalmic Drugs: Supports affordable alternatives for glaucoma treatment.
Process Development: Facilitates route optimization and scalability studies.
Quality Control: Reference material for analytical method validation.
🏅 Quality Certifications
Rigorous testing via HPLC, GC, NMR, and Mass Spectrometry (USP/EP/ICH compliant).
Batch-specific Certificate of Analysis (CoA) with full traceability.
🌐 Market Trends
The pharmaceutical intermediates market is projected to grow at 6.3% CAGR (2024-2030), driven by rising glaucoma cases and demand for generic APIs. Brinzolamide intermediates are essential to meet global production needs for ophthalmic therapeutics.
🔍 Why Choose Us?
Custom Synthesis: Tailored solutions for bulk API manufacturing.
Fast Delivery: Global shipping with cold-chain logistics for sensitive compounds.
Technical Support: End-to-end assistance in API development and regulatory compliance.